FDA 483 - RK Pharma Inc. - August 12, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
RK Pharma Inc. in Pearl River, NY, a sterile drug manufacturer, was cited for significant deficiencies during an FDA inspection. Observations included a lack of quality control unit authority over production records and investigations, inadequately qualified manufacturing and testing equipment, and insufficient cleaning and maintenance procedures. Additionally, the firm failed to follow written production and process control procedures, indicating systemic issues in their quality management system.
ID · 5e26c4c2-1c01-4674-bfd8-3146fd524e34